Singh N - Search Results

1

Hepatic iron content and the risk of Staphylococcus aureus bacteremia in liver transplant recipients.

Singh N, Wannstedt C, Keyes L, Mayher D, Tickerhoof L, Akoad M, Wagener MM, Frye R, Cacciarelli TV. Singh N, et al. Prog Transplant. 2007 Dec;17(4):332-6. doi: 10.1177/152692480701700412. Prog Transplant. 2007. PMID: 18240700

2

Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices.

Singh N, Wagener MM, Marino IR, Gayowski T. Singh N, et al. Transplantation. 2002 Jan 15;73(1):63-7. doi: 10.1097/00007890-200201150-00011. Transplantation. 2002. PMID: 11792979

3

Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients.

Singh N, Husain S, Carrigan DR, Knox KK, Weck KE, Wagener MM, Gayowski T. Singh N, et al. Clin Transplant. 2002 Apr;16(2):92-6. doi: 10.1034/j.1399-0012.2002.1o096.x. Clin Transplant. 2002. PMID: 11966777

4

Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit.

Squier C, Rihs JD, Risa KJ, Sagnimeni A, Wagener MM, Stout J, Muder RR, Singh N. Squier C, et al. Among authors: singh n. Infect Control Hosp Epidemiol. 2002 Sep;23(9):495-501. doi: 10.1086/502095. Infect Control Hosp Epidemiol. 2002. PMID: 12269445

5

Impact of donor bacteremia on outcome in organ transplant recipients.

Singh N. Singh N. Liver Transpl. 2002 Oct;8(10):975-6. doi: 10.1053/jlts.2002.0080975. Liver Transpl. 2002. PMID: 12360445 Free article. No abstract available.

6

Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis.

Singh N, Wagener MM, Gayowski T. Singh N, et al. Transplantation. 2002 Sep 27;74(6):892-5. doi: 10.1097/01.TP.0000027945.73198.66. Transplantation. 2002. PMID: 12364876

7

Legionnaires's disease in a transplant recipient acquired from the patient's home: implications for management.

Singh N, Stout JE, Yu VL. Singh N, et al. Transplantation. 2002 Sep 27;74(6):755-6. Transplantation. 2002. PMID: 12369582 No abstract available.

8

Alternative therapy use in HIV-infected patients receiving highly active antiretroviral therapy.

Risa KJ, Nepon L, Justis JC, Panwalker A, Berman SM, Cinti S, Wagener MM, Singh N. Risa KJ, et al. Among authors: singh n. Int J STD AIDS. 2002 Oct;13(10):706-13. doi: 10.1258/095646202760326471. Int J STD AIDS. 2002. PMID: 12396542

9

Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates.

Paterson DL, Rihs JD, Squier C, Gayowski T, Sagnimeni A, Singh N. Paterson DL, et al. Among authors: singh n. Transplantation. 2003 Jan 27;75(2):194-8. doi: 10.1097/01.TP.0000040602.01701.85. Transplantation. 2003. PMID: 12548122

10

Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study.

Husain S, Tollemar J, Dominguez EA, Baumgarten K, Humar A, Paterson DL, Wagener MM, Kusne S, Singh N. Husain S, et al. Among authors: singh n. Transplantation. 2003 Jun 27;75(12):2023-9. doi: 10.1097/01.TP.0000065178.93741.72. Transplantation. 2003. PMID: 12829905 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,640 results

Search Page

Filters